N-Acetyl Cysteine (NAC)
Precursor to glutathione, the body's master antioxidant. Supports liver health, respiratory function, and detoxification.
Projected serum levels — 600 mg, once daily
Maintenance schedule: 600 mg once daily (oral).
Modeled steady state after ~1 days: peak ≈ 57.5 mg, trough ≈ 4.7 mg body load. Population-based estimate over 15 days for a 600 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Amino Acid
- Route modeled
- Oral
- Model confidence
- inferred
- Half-life
- 6.3 h
- Common dose
- 600 mg
- Suggested maximum
- 2.4k mg/day
- Reference dose range
- 300–2.4k mg (single dose)
- Suggested cadence
- once daily
- Validated against
- 600 mg oral — Cmax 4 mg/L at 1 h
Documented interactions
-
caution
Sulforaphane (Broccoli Seed Extract) + N-Acetyl Cysteine (NAC)
NAC is a potent antioxidant that may blunt the hormetic (mild oxidative stress) signal that sulforaphane uses to activate Nrf2 antioxidant pathways. This could reduce sulforaphane effectiveness.
-
caution
Zinc (Picolinate) + N-Acetyl Cysteine (NAC)
NAC chelates zinc and copper, potentially reducing their bioavailability over time.
-
watch
Glutathione (Injectable) + N-Acetyl Cysteine (NAC)
Glutathione (Injectable) and N-Acetyl Cysteine (NAC) both push the endogenous glutathione pool in the same direction.
-
watch
Milk Thistle (Silymarin / Silybin) + N-Acetyl Cysteine (NAC)
Milk Thistle (Silymarin / Silybin) and N-Acetyl Cysteine (NAC) both push the endogenous glutathione pool in the same direction.
-
watch
MSM (Methylsulfonylmethane) + N-Acetyl Cysteine (NAC)
MSM (Methylsulfonylmethane) and N-Acetyl Cysteine (NAC) both push the endogenous sulfur pool in the same direction.
-
watch
PQQ (Pyrroloquinoline Quinone) + N-Acetyl Cysteine (NAC)
N-Acetyl Cysteine (NAC) and PQQ (Pyrroloquinoline Quinone) both push the endogenous glutathione pool in the same direction.
Serum checks 7 modeled interaction pairings for n-acetyl cysteine (nac) across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.
Research behind this entry
-
Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis
Meta-analysis of 20 RCTs found NAC reduced the risk of contrast-induced nephropathy by approximately 40% when given before contrast procedures.
-
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
Review of NAC in psychiatric conditions found evidence supporting its use as adjunctive therapy for depression, bipolar disorder, and obsessive-compulsive disorder through glutathione and glutamate modulation.
-
Acetylcysteine for acetaminophen poisoning
Landmark study establishing NAC as the standard treatment for acetaminophen overdose, preventing liver failure when administered within 8-10 hours of ingestion.
-
Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985).
This citation reports a human clinical study involving N-Acetyl Cysteine (NAC). It does not by itself establish a qualified dose, safety profile, efficacy claim, or pharmacokinetic route for this record.
4 published studies referenced in the app, each with a plain-language summary.